1. Home
  2. AXDX vs ALUR Comparison

AXDX vs ALUR Comparison

Compare AXDX & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXDX
  • ALUR
  • Stock Information
  • Founded
  • AXDX 1982
  • ALUR 2009
  • Country
  • AXDX United States
  • ALUR United States
  • Employees
  • AXDX N/A
  • ALUR N/A
  • Industry
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • ALUR
  • Sector
  • AXDX Industrials
  • ALUR
  • Exchange
  • AXDX Nasdaq
  • ALUR Nasdaq
  • Market Cap
  • AXDX 13.7M
  • ALUR 19.1M
  • IPO Year
  • AXDX 1996
  • ALUR N/A
  • Fundamental
  • Price
  • AXDX $0.14
  • ALUR $2.36
  • Analyst Decision
  • AXDX
  • ALUR Strong Buy
  • Analyst Count
  • AXDX 0
  • ALUR 3
  • Target Price
  • AXDX N/A
  • ALUR $22.83
  • AVG Volume (30 Days)
  • AXDX 425.6K
  • ALUR 59.9K
  • Earning Date
  • AXDX 05-16-2025
  • ALUR 05-14-2025
  • Dividend Yield
  • AXDX N/A
  • ALUR N/A
  • EPS Growth
  • AXDX N/A
  • ALUR N/A
  • EPS
  • AXDX N/A
  • ALUR N/A
  • Revenue
  • AXDX $11,698,000.00
  • ALUR $32,110,000.00
  • Revenue This Year
  • AXDX $7.25
  • ALUR N/A
  • Revenue Next Year
  • AXDX N/A
  • ALUR $38.86
  • P/E Ratio
  • AXDX N/A
  • ALUR N/A
  • Revenue Growth
  • AXDX N/A
  • ALUR N/A
  • 52 Week Low
  • AXDX $0.12
  • ALUR $2.15
  • 52 Week High
  • AXDX $2.09
  • ALUR $88.75
  • Technical
  • Relative Strength Index (RSI)
  • AXDX 14.62
  • ALUR 41.81
  • Support Level
  • AXDX $0.50
  • ALUR $2.25
  • Resistance Level
  • AXDX $0.56
  • ALUR $2.52
  • Average True Range (ATR)
  • AXDX 0.05
  • ALUR 0.15
  • MACD
  • AXDX -0.01
  • ALUR 0.04
  • Stochastic Oscillator
  • AXDX 4.44
  • ALUR 50.79

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: